SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Baird Maintains Outperform on Exact Sciences, Raises Price Target to $92

Baird maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and raises the price target from $90 to $92.

Benzinga · 05/07/2020 15:55

Baird maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and raises the price target from $90 to $92.